Patent details

Basic Information

Publication number:

EP2496582

PCT Application Number:

PCT/EP/2010/066697

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107733255

PCT Publication Number:

WO/2011/054845

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BENZODIAZEPINE BROMODOMAIN INHIBITOR

French Title of Invention:

INHIBITEUR DE BROMODOMAINES VIS-À-VIS DE LA BENZODIAZÉPINE

German Title of Invention:

BENZODIAZEPIN-BROMODOMÄNENHEMMER

SPC Number:

Dates

Filing date:

03/11/2010

Grant date:

27/01/2016

EP Publication Date:

27/01/2016

PCT Publication Date:

12/05/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/09/2012

EP B1 Publication Date:

27/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/11/2021

Expiration date:

03/11/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/01/2018

 

 

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

History of Owners

From:

19/04/2016

To:

10/01/2018

Name:

GlaxoSmithKline LLC

Address:

Corporation Service Company 2711 Centerville Road Suite 40, Wilmington DE 19808, United States (US)

Agent

Name:

KIRKPATRICK SA / NV

From:

21/03/2016

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

WITHERINGTON Jason

Address:

United Kingdom (GB)

2

Name:

BAILEY James

Address:

United Kingdom (GB)

3

Name:

GOSMINI Romain, Luc, Marie

Address:

France (FR)

4

Name:

MIRGUET Olivier

Address:

France (FR)

Priority

1

Priority Number:

0919433

Priority Date:

05/11/2009

Priority Country:

United Kingdom (GB)

2

Priority Number:

201010509

Priority Date:

22/06/2010

Priority Country:

United Kingdom (GB)

3

Priority Number:

0/061518

Priority Date:

06/08/2010

Priority Country:

European Patent Office (EPO) (EP)

4

Priority Number:

201014231

Priority Date:

25/08/2010

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 487/04;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2018/03

Publication date:

20/02/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000011A

Date Registered:

10/01/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changements de noms et d'adresses

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

15/10/2020

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

148 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
10/01/2018	Request For Change	4
11/01/2018	Outgoing Correspondence	1